共 114 条
[1]
Buss N(2012)Monoclonal antibody therapeutics: history and future Curr Opin Pharmacol. 12 615-22
[2]
Henderson S(2011)Advances in the production and downstream processing of antibodies N Biotechnol. 28 458-63
[3]
Chon JH(1975)Continuous cultures of fused cells secreting antibody of predefined Nature. 256 495-7
[4]
Zarbis-Papastoitsis G(2001)Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies Int Immunol. 13 1551-9
[5]
Köhler G(2005)Immunogenicity of engineered antibodies Methods. 36 3-10
[6]
Milstein C(1984)Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains Proc Natl Acad Sci U S A. 81 6851-5
[7]
Ober RJ(2008)Monoclonal antibodies as innovative therapeutics Curr Pharm Biotechnol. 9 423-30
[8]
Radu CG(2010)Development trends for human monoclonal antibody therapeutics Nat Rev Drug Discov. 9 767-74
[9]
Ghetie V(2013)Entry strategies in an emerging technology: a pilot web-based study of graphene firms Scientometrics. 95 1189-207
[10]
Ward ES(2013)Management innovation and adoption of emerging technologies: the case of cloud computing Eur Manag Rev. 10 51-67